Kyle Fargen to Fibrinolytic Agents
This is a "connection" page, showing publications Kyle Fargen has written about Fibrinolytic Agents.
Connection Strength
1.137
-
Fargen KM, Hoh BL, Fautheree GL, Morgan WR, Velat GJ, Waters MF, Mocco J. Aggressive intervention to treat a young woman with intracranial hemorrhage following unsuccessful intravenous thrombolysis for left middle cerebral artery occlusion. Case report. J Neurosurg. 2011 Aug; 115(2):359-63.
Score: 0.369
-
Fargen KM, Bhasin RR, Murad GJ. Abdominal craniectomy implantation and thromboembolism prophylaxis resulting in wound hematoma. Neurosurgery. 2010 Aug; 67(2):495-7.
Score: 0.351
-
Townsend RK, Wolfe SQ, Anadani M, Spiotta A, De Leacy R, Mocco J, Garner RM, Albuquerque FC, Ducruet AF, Kan P, Fargen KM. Endovascular management of acute postprocedural flow diverting stent thrombosis. J Neurointerv Surg. 2020 Jan; 12(1):67-71.
Score: 0.165
-
Fargen KM, Neal D, Fiorella DJ, Turk AS, Froehler M, Mocco J. A meta-analysis of prospective randomized controlled trials evaluating endovascular therapies for acute ischemic stroke. J Neurointerv Surg. 2015 Feb; 7(2):84-9.
Score: 0.118
-
Khalessi AA, Fargen KM, Lavine S, Mocco J. Commentary: Societal statement on recent acute stroke intervention trials: results and implications. Neurosurgery. 2013 Aug; 73(2):E375-9.
Score: 0.108
-
Turk AS, Magarick JA, Frei D, Fargen KM, Chaudry I, Holmstedt CA, Nicholas J, Mocco J, Turner RD, Huddle D, Loy D, Bellon R, Dooley G, Adams R, Whaley M, Fanale C, Jauch E. CT perfusion-guided patient selection for endovascular recanalization in acute ischemic stroke: a multicenter study. J Neurointerv Surg. 2013 Nov; 5(6):523-7.
Score: 0.026